Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis-Reference-Cited by-同舟云学术

Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis

Published:2020-04-24 Issue:6 Volume:40 Page:1316-1320
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Mantovani Alessandro¹^ORCID,Beatrice Giorgia¹,Dalbeni Andrea²^ORCID

Affiliation:

1. Section of Endocrinology, Diabetes and Metabolism Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy

2. Section of General Medicine Hypertension and Liver Unit University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14465

Reference17 articles.

1. https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019. Accessed March 26 2020.

2. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

3. COVID-19 and the liver: little cause for concern

4. Liver injury in COVID-19: management and challenges

5. Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals;International Journal of Molecular Sciences;2024-08-03

3. Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?;Journal of Clinical Medicine;2024-05-03

4. Impacto de COVID-19 en enfermedad hepatica pre-existente;Cirugía y Cirujanos;2024-03-12

5. Protective effects of hepatic diseases by bioactive phytochemicals in Fusarium oxysporum – A review;Heliyon;2024-03